AbbVie staves off Rinvoq generics until 2037news2025-09-11T19:11:19+00:00September 11th, 2025|Endpoints News|
Intercept pulls liver disease drug from market as FDA puts clinical trials on holdnews2025-09-11T14:48:53+00:00September 11th, 2025|Endpoints News|
SEC files charges against former FibroGen CMO for manipulating clinical trial datanews2025-09-11T11:09:03+00:00September 11th, 2025|Endpoints News|
Merck cancels plans for $1.3B London labnews2025-09-10T19:43:00+00:00September 10th, 2025|Endpoints News|
Biocon eyes generic semaglutide market for 2026news2025-09-10T19:00:54+00:00September 10th, 2025|Endpoints News|
Pharma’s drug discount fight intensifies as state 340B cases reach higher courtsnews2025-09-10T18:47:44+00:00September 10th, 2025|Endpoints News|
API maker Hikal hit with FDA warning letter over alleged metal contaminationnews2025-09-10T15:22:44+00:00September 10th, 2025|Endpoints News|
FDA blocks US imports from Sun Pharma’s Halol site over repeated issuesnews2025-09-10T13:59:27+00:00September 10th, 2025|Endpoints News|
Hims expands into hormone health with men’s testosterone treatmentnews2025-09-10T13:00:01+00:00September 10th, 2025|Endpoints News|
